Brief: Bergenbio's Bemcentinib Selected To Be Fast-Tracked

Oncoinvent ASA

29/04/2020 06:05

April 29 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO'S BEMCENTINIB SELECTED TO BE FAST-TRACKED AS
POTENTIAL
TREATMENT
    * BEMCENTINIB SELECTED AS FIRST CANDIDATE TO BE TESTED
THROUGH NEW
ACCORD STUDY
    * PHASE II CLINICAL TRIAL INITIATIVE TO RAPIDLY INVESTIGATE
BEMCENTINIB'S EFFICACY AND SAFETY IN HOSPITALISED COVID-19
PATIENTS

Source text for Eikon:  ID:nObip21Jja 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))